Insider · CIK 0001705850
Joseph E Gilliam
coopresidentofficer
Files at GKOS (GLAUKOS Corp). First filing Nov 1, 2024, latest Dec 23, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $815k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
GKOS: GLAUKOS Corp
GKOSOct 9, 2026 · close 165.69
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 11Weak | GLAUKOS Corp | $499k 3,328 shares | -3% | - | |
| 0Weak | GLAUKOS Corp | $316k 2,275 shares | -2% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 23, 2025 | GKOS GLAUKOS Corp | FTax withholding Common Stock | -1,056 | $84.69 | $89k | 111,706 | Sep 24, 2025 |
| Sep 18, 2025 | GKOS GLAUKOS Corp | AGrant or award Common Stock | +3,884 | $0.00 | $0 | 112,762 | Sep 22, 2025 |
| May 28, 2025 | GKOS GLAUKOS Corp | FTax withholding Common Stock | -1,057 | $96.97 | $102k | 108,711 | May 30, 2025 |
| Apr 1, 2025 | GKOS GLAUKOS Corp | FTax withholding Common Stock | -1,922 | $97.09 | $187k | 109,768 | Apr 2, 2025 |
| Mar 25, 2025 | GKOS GLAUKOS Corp | FTax withholding Common Stock | -13,429 | $107.61 | $1.4M | 114,581 | Mar 27, 2025 |
| Mar 25, 2025 | GKOS GLAUKOS Corp | FTax withholding Common Stock | -2,891 | $96.60 | $279k | 111,690 | Mar 27, 2025 |
| Mar 13, 2025 | GKOS GLAUKOS Corp | AGrant or award Common Stock | +3,888 | $0.00 | $0 | 105,093 | Mar 17, 2025 |
| Mar 13, 2025 | GKOS GLAUKOS Corp | AGrant or award Common Stock | +5,829 | $0.00 | $0 | 110,922 | Mar 17, 2025 |
| Mar 13, 2025 | GKOS GLAUKOS Corp | AGrant or award Common Stock | +18,116 | $0.00 | $0 | 129,038 | Mar 17, 2025 |
| Mar 17, 2025 | GKOS GLAUKOS Corp | FTax withholding Common Stock | -1,028 | $102.19 | $105k | 128,010 | Mar 17, 2025 |
| Mar 13, 2025 | GKOS GLAUKOS Corp | AGrant or award Stock Option (Right to Buy)derivative | +13,271 | $0.00 | $0 | 35,713 | Mar 17, 2025 |
| Dec 20, 2024 | GKOS GLAUKOS Corp | FTax withholding Common Stock | -964 | $138.93 | $134k | 101,205 | Jan 2, 2025 |
| Dec 30, 2024 | GKOS GLAUKOS Corp | AGrant or award Stock Option (Right to Buy)derivative | +7,318 | $0.00 | $0 | 57,697 | Jan 2, 2025 |
| Dec 20, 2024 | GKOS GLAUKOS Corp | MOption exercise Common Stock10b5-1 | +1,053 | $39.10 | $41k | 103,222 | Dec 23, 2024 |
| Dec 20, 2024 | GKOS GLAUKOS Corp | MOption exercise Common Stock10b5-1 | +2,275 | $69.30 | $158k | 105,497 | Dec 23, 2024 |
| Dec 20, 2024 | GKOS GLAUKOS Corp | SOpen-market sale Common Stock10b5-1 | -2,036 | $149.54 | $304k | 103,461 | Dec 23, 2024 |
| Dec 20, 2024 | GKOS GLAUKOS Corp | SOpen-market sale Common Stock10b5-1 | -1,292 | $150.35 | $194k | 102,169 | Dec 23, 2024 |
| Dec 20, 2024 | GKOS GLAUKOS Corp | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,053 | $0.00 | $0 | 0 | Dec 23, 2024 |
| Dec 20, 2024 | GKOS GLAUKOS Corp | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,275 | $0.00 | $0 | 431 | Dec 23, 2024 |
| Oct 30, 2024 | GKOS GLAUKOS Corp | MOption exercise Common Stock10b5-1 | +2,275 | $69.30 | $158k | 104,444 | Nov 1, 2024 |
| Oct 30, 2024 | GKOS GLAUKOS Corp | SOpen-market sale Common Stock10b5-1 | -2,275 | $138.97 | $316k | 102,169 | Nov 1, 2024 |
| Oct 30, 2024 | GKOS GLAUKOS Corp | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,275 | $69.30 | $158k | 2,706 | Nov 1, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.